- CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Grotta, J.C., Picone, C.M., Ostrow, P.T., Strong, R.A., Earls, R.M., Yao, L.P., Rhoades, H.M., Dedman, J.R. Ann. Neurol. (1990)